Profilo
John Le Gall is currently Chief Medical Officer at Imugene Ltd., starting in 2026.
Formerly, Dr. Le Gall was Vice President & Head-Clinical Development at Allogene Therapeutics, Inc. from 2023 to 2026.
Education includes an MBA and a doctorate from The Trustees of Columbia University in The City of New York.
Posizioni attive di John Le Gall
| Società | Posizione | Inizio |
|---|---|---|
| IMUGENE LIMITED | Direttore Tecnico/Scientifico/R&S | 07/10/2026 |
Precedenti posizioni note di John Le Gall
| Società | Posizione | Fine |
|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2026 |
Formazione di John Le Gall
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imugene Ltd.
Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
















